Navigation Links
Medpace Strengthens Presence in Central Europe
Date:8/21/2007

CINCINNATI and PRAGUE, Czech Republic, Aug. 21 /PRNewswire/ -- Medpace, Inc., a leading global full-service contract research organization, today announced it has completed the acquisition of Monax s.r.o., a regional contract research organization (CRO) headquartered in Prague, Czech Republic. This move strengthens the Medpace presence in Central Europe and expands its capacity to provide full service clinical research management within the Czech Republic and Slovakia. Petr Potuznik, MD, the founder of Monax, will continue to lead Medpace clinical operations for the region.

"We are excited to welcome the Monax team to the Medpace family," said August Troendle, MD, Medpace Chief Executive Officer. "The expertise of Dr. Petr Potuznik and his highly trained team fit perfectly within our strategic global expansion plan."

"We have worked closely with Medpace in the past and found that our companies shared a high level of expertise and commitment to quality," said Potuznik. "Becoming part of the Medpace group allows the Monax team to grow and expand our presence and capabilities throughout the region."

About Medpace

Medpace is a global, research-based drug development company led by top therapeutic and regulatory experts who are driven to further the advancement of pharmaceutical agents for use in cardiology, metabolism, and oncology. Medpace has assembled the industry's most experienced and therapeutically focused team to execute at every level of the company's operations, providing complete and seamless drug development services.

Through specialized regulatory expertise and therapeutically focused clinical operations, Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development - from program planning and execution to product approval.

With more than 500 employees and clinical trial experience in nearly 40 countries, Medpace has
'/>"/>

SOURCE Medpace, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BIO 2007: Wisconsin makes its presence felt
2. TDS trades markets to gain Duluth presence
3. West Coast VC Establishes Midwest Presence in Madison
4. Sony Bets Heavy on Wisconsin Digital Entertainment Presence
5. Madison start-up Central Signal gets $350K grant
6. Will wireless Internet bypass the central city?
7. Norlight to expand fiber network into central Illinois
8. Centralization mania takes over
9. Meterologix Media Division acquired by Madison-based Weather Central
10. Weather Central launches second satellite
11. Development of an NK2 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Call/ -- BioMarin Pharmaceutical,Inc. (Nasdaq: ...hief Medical,Officer will retire from the company... leave his position with the company to allow him ... endeavors related to rare diseases. Dr.,Kakkis ...or the foreseeable,future. , "I am extreme...
(Date:11/21/2008)...Call/ -- CorVel Corporation,(Nasdaq: CRVL ) ann...er the new,Medicare legislation requiring expande...ors and employers. The Company currently provides...ompensation and general liability,customers throu...ffering to,include communications soon to be mand...
(Date:11/21/2008)...e Center is First Integrated Knowledge Center Outs...Hyderabad, India (Vocus) November 21, 2008 -&ndash...today, 17 months after breaking ground last summer... in the city’s Genome Valley, the center wil... region in the areas of agricultural and industria...
(Date:11/21/2008)...UCTURING ALTERNATIVES ONGOING , , VANCOUVER...aceuticals, Inc. (NASDAQ: ANPI , TSX: ANP), a gl...ompany, today announced that the Company had been ...nture Partners (New Leaf) that they had elected to...7, 2008. Angiotech had announced on September 22, ...
Breaking Biology Technology:BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 2BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 3BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 4CorVel Announces MSA Agent Services 2CorVel Announces MSA Agent Services 3DuPont Opens Research & Development Center in India 2DuPont Opens Research & Development Center in India 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 2Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 3Angiotech announces termination of note purchase agreement with Ares Management and New Leaf Venture Partners 4
... Stratagenes custom molecular beacon synthesis a... , Fei Bao , University of Colorad... We used Stratagenes custom molecular beacons ff,...NP) in a region of chromosome,10q25.1 and showed...s carried in,family members. This molecular beac...
...,,,, Culture 192 clones simul...ff Braman ,Stratagene , , , F... , The tempest thermoshaker and a 96-deep-w...ate bacterial clones in a, high-throughput ...l growth, were equivalent in aerated and no...
...,, Many different tissue types on a con...as ,Stratagene , Stratagenes Complete View t...issue array technology through optimized,tissue ...issue morphology,antigenicity of proteins, and ...,line consists of murine (male and female) survey ...
... Produce large quantities of difficult-to-express...rd Becker ,Biochemical & Molecular Allergology, ...tagenes BL21-CodonPlus(DE3)-RIL cells * with,ext...nes,it is possible to attain high-level express... usage: IPTG-induced expression of several recombi...
Other Biology Technology:Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 2Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 3Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 4Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 5Genotyping Single Nucleotide Polymorphisms with Molecular Beacons 6High-Throughput Cultivation of Bacterial Clones 2High-Throughput Cultivation of Bacterial Clones 3Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 2Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 3Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 4Innovative Tissue Array Technology for High-Throughput Screening of Gene,Expression 5High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4
(Date:11/20/2008)...the ocean floor made by giant deep-sea single-cell...volutionary origin of animals, says biologist Mikh...ustin. , Matz and his colleagues recently disco...racks on the ocean floor near the Bahamas. This is...shown to make such animal-like traces. , The fin...
(Date:11/20/2008)...gical Institute at St. Joseph,s Hospital and Medic...e motions and the perception of illusory motion th...knik, PhD, director of the Laboratory of Behaviora...ector of the Laboratory of Visual Neuroscience; Xo...ucted a study based on the Enigma painting, a visu...
(Date:11/20/2008)...A team led by Thomas Schulthess of the U.S. Depart...eived the prestigious 2008 Association for Computi...r attaining the fastest performance ever in a scie...is group leader of ORNL,s Computational Materials ...director of the Swiss National Supercomputing Cent...
(Date:11/20/2008)... hates strangers. When its security patrol spots a...problem when people with type 1 diabetes undergo h...rom a donor pancreas produce robust amounts of ins...dence from insulin therapy. However, the immune sy... A person who has the transplant procedure must t...
Breaking Biology News(10 mins):Discovery of giant roaming deep sea protist provides new perspective on animal evolution 2Discovery of giant roaming deep sea protist provides new perspective on animal evolution 3ORNL supercomputer simulation wins prize for fastest-running science application 2ORNL supercomputer simulation wins prize for fastest-running science application 3Researcher tricks immune system in diabetic mice 2Video 3A Never Feel Bad About Your Neck Again 3A 27880 1Video 3A Never Feel Bad About Your Neck Again 3A 27880 2Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals 27876 1Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals 27876 2Catalyst Biosciences Appoints Dr Todd Lorenz Chief Medical Officer 27872 1Catalyst Biosciences Appoints Dr Todd Lorenz Chief Medical Officer 27872 2Catalyst Biosciences Appoints Dr Todd Lorenz Chief Medical Officer 27872 3PEAK Surgical Introduces PlasmaBlade 28TM 29 Product Line Extensions for Use in General Surgery 8655 1PEAK Surgical Introduces PlasmaBlade 28TM 29 Product Line Extensions for Use in General Surgery 8655 2PEAK Surgical Introduces PlasmaBlade 28TM 29 Product Line Extensions for Use in General Surgery 8655 3
...f Medicine researchers have discovered how new neu...nt to regions of the brain where they can replace ...tem cell therapies can be specifically targeted to...ses or by stroke. , Associate Professor Qun-Yong Z...artment of Pharmacology have identified a protein ...
... the world are breathing a sigh of relief, as they...ir natural disease-fighting substances. Scientists... didemnii, which lives symbiotically inside the se...es, compounds that may one day be used in cancer t...s could not successfully cultivate Prochloron in t...
...sma protein found in blood, can be fused with larg...stimulating factor (G-CSF) to create a new oral co...rough the gastrointestinal (GI) tract and then abl... the body, according to research from the Universi...is technology may allow for oral administration of...
...factors prove that BioMed Central,s Open Access jo... Journals published by BioMed Central have again r...valent subscription titles, it was announced today...lty. The high impact factors for these journals af...re fast becoming the place for authors to submit i...
Other Biology News:Researchers discover stem cell 'guide' that may be key for targeting neural stem cell treatments 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 2Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs 3'Bionic' arm gives amputee sense of touch 2
Protein Marker Detection Pack contains biotinylate
JMJD2B Antibody
Agarose, Biotechnology grade, 500g
...to-oncogene was first identified as the cellular h...Jun B and Jun D have been shown to be almost ident...re involved in dimerization and DNA binding, where... transcriptional activation, diverge. Antigen: ...
Biology Products: